CARRECA I, F BELLOMO, G BRONTE, M BURGIO, D PIAZZA, S RIZZO, et al. (2007). Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).. In The 2007 Breast Cancer Symposium Proceedings Book (pp.158-158).

Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).

CARRECA, Ignazio;BELLOMO, Fernanda Manuela;BRONTE, Giuseppe;
2007-01-01

2007 Breast Cancer Symposium
San Francisco, California
September 7-8, 2007
2007
Abstract N. 201
CARRECA I, F BELLOMO, G BRONTE, M BURGIO, D PIAZZA, S RIZZO, et al. (2007). Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).. In The 2007 Breast Cancer Symposium Proceedings Book (pp.158-158).
Proceedings (atti dei congressi)
CARRECA I; F BELLOMO; G BRONTE; M BURGIO; D PIAZZA; S RIZZO; S RUSSO; L BALDUCCI
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/12483
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact